• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by GSK plc

    9/19/25 6:07:04 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $GSK alert in real time by email
    6-K 1 a9586z.htm TRANSACTION IN OWN SHARES a9586z
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    Form 6-K
     
    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934
     
     
     
    For the month of September 2025
     
    Commission File Number 001-15170
     
     
    GSK plc
    (Translation of registrant's name into English)
     
     
    79 New Oxford Street, London, WC1A 1DG
    (Address of principal executive office)
     
     
     
    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
     
    Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
     
     
                                   
     
    Transaction in own shares
     
    GSK plc (the "Company") announces today acting through its corporate stockbroker, Merrill Lynch International (the "Broker"), it has purchased the following number of the Company's ordinary shares of 31¼ pence each.
     
     
    Date of purchase:
    18 September 2025
    Aggregate number of ordinary shares of 31¼ pence each purchased: 
    15,858
    Lowest price paid per share (GBp):
    1,471.00p
    Highest price paid per share (GBp):
    1,480.00p
    Volume-weighted average price paid per share (GBp):
    1,476.54p
     
    The purchased shares will be held as Treasury shares.
     
    Such purchase forms part of the Company's existing buyback programme and was effected pursuant to the non-discretionary agreement entered into with the Broker on 4 June 2025, as announced on 4 June 2025. Since 4 June 2025 the Company has purchased 29,330,461 ordinary shares.
     
    Following the above purchase, the Company will hold 247,464,844 ordinary shares in treasury and have 4,067,938,124 ordinary shares in issue (excluding Treasury shares).
     
    The total number of voting rights in the Company is 4,067,938,124. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
     
    The Company confirms that, in accordance with DTR 5.5.1R, following the above purchase the percentage of voting rights attributable to the ordinary shares held in treasury is 6.08 per cent.
     
    The table below contains detailed information of the individual trades made by the Broker on the London Stock Exchange and the CBOE Europe Limited recognised investment exchange (through its order books having market identification codes CHIX or BATE) as part of the buyback programme.
     
     
    Schedule of Purchases
     
    Shares purchased:       GSK plc (ISIN: GB00BN7SWP63)
     
    Date of purchases:      18 September 2025
     
    Investment firm:         Merrill Lynch International
     
     
    Aggregated information per trading venue:
     
    Venue
    Number of ordinary shares purchased
    Highest price paid (per ordinary share) (GBp)
    Lowest price paid (per ordinary share) (GBp)
    Volume weighted average price paid (per ordinary share) (GBp)
    London Stock Exchange (XLON)
    15,858
    1,480.00p
    1,471.00p
    1,476.54p
    CBOE (CHIX)
    0
    -
    -
    -
    CBOE (BATE)
    0
    -
    -
    -
     
     
    Individual transactions:
     
    Number of Shares
    Price per Share (GBp)
    Trading venue
    Date of
    transaction
    Time of
    transaction
    Transaction reference number
    2
    1,480.00
     XLON
    18-Sep-2025
    08:00:50
    0XL0640000000000ARCLI8
    12
    1,480.00
     XLON
    18-Sep-2025
    08:00:50
    0XL0614000000000ARCLLA
    14
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL06A0000000000ARCLK0
    13
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL0611000000000ARCLJT
    2
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL0640000000000ARCLIB
    12
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL06D0000000000ARCLNR
    13
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL0611000000000ARCLJS
    12
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL0640000000000ARCLIA
    3
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL0614000000000ARCLLB
    12
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL0640000000000ARCLI9
    13
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL06D0000000000ARCLNP
    1,393
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL0617000000000ARCLQN
    3
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL06A0000000000ARCLJV
    13
    1,480.00
     XLON
    18-Sep-2025
    08:00:50
    0XL0617000000000ARCLQM
    13
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL0610000000000ARCLC8
    11
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL06D0000000000ARCLNS
    13
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL06D0000000000ARCLNQ
    14
    1,479.50
     XLON
    18-Sep-2025
    08:00:50
    0XL06D0000000000ARCLNT
    1,067
    1,479.00
     XLON
    18-Sep-2025
    08:01:04
    0XL0617000000000ARCLRP
    12
    1,479.00
     XLON
    18-Sep-2025
    08:01:04
    0XL0617000000000ARCLRO
    12
    1,479.00
     XLON
    18-Sep-2025
    08:01:04
    0XL0614000000000ARCLLR
    12
    1,479.00
     XLON
    18-Sep-2025
    08:01:04
    0XL0617000000000ARCLRN
    212
    1,478.50
     XLON
    18-Sep-2025
    08:01:15
    0XL0617000000000ARCLSF
    499
    1,478.00
     XLON
    18-Sep-2025
    08:02:28
    0XL0617000000000ARCLVK
    22
    1,478.00
     XLON
    18-Sep-2025
    08:02:28
    0XL0614000000000ARCLQA
    10
    1,478.00
     XLON
    18-Sep-2025
    08:02:28
    0XL0614000000000ARCLQ9
    2
    1,477.50
     XLON
    18-Sep-2025
    08:02:39
    0XL0614000000000ARCLQJ
    5
    1,477.50
     XLON
    18-Sep-2025
    08:02:39
    0XL06A0000000000ARCLR0
    258
    1,477.50
     XLON
    18-Sep-2025
    08:02:39
    0XL0617000000000ARCLVS
    8
    1,477.50
     XLON
    18-Sep-2025
    08:02:39
    0XL0617000000000ARCLVR
    12
    1,477.50
     XLON
    18-Sep-2025
    08:02:39
    0XL06D0000000000ARCLUU
    5
    1,477.50
     XLON
    18-Sep-2025
    08:02:39
    0XL0640000000000ARCLNJ
    20
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL0610000000000ARCLJF
    22
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL06D0000000000ARCLVG
    13
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL06A0000000000ARCLSG
    22
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL0611000000000ARCLPM
    23
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL0611000000000ARCLPL
    23
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL06A0000000000ARCLSH
    23
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL06D0000000000ARCLVF
    22
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL0640000000000ARCLOF
    22
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL06D0000000000ARCLVH
    20
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL0640000000000ARCLOE
    21
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL06D0000000000ARCLVI
    344
    1,477.00
     XLON
    18-Sep-2025
    08:02:53
    0XL0617000000000ARCM0E
    8
    1,476.50
     XLON
    18-Sep-2025
    08:02:56
    0XL06D0000000000ARCLVK
    3
    1,476.50
     XLON
    18-Sep-2025
    08:02:56
    0XL06A0000000000ARCLSL
    11
    1,476.50
     XLON
    18-Sep-2025
    08:02:56
    0XL0614000000000ARCLRG
    3
    1,476.50
     XLON
    18-Sep-2025
    08:02:56
    0XL0614000000000ARCLRH
    22
    1,476.50
     XLON
    18-Sep-2025
    08:02:56
    0XL0617000000000ARCM0I
    270
    1,476.00
     XLON
    18-Sep-2025
    08:03:28
    0XL0617000000000ARCM16
    10
    1,476.00
     XLON
    18-Sep-2025
    08:03:28
    0XL06A0000000000ARCLTT
    3
    1,475.50
     XLON
    18-Sep-2025
    08:04:08
    0XL0617000000000ARCM31
    3
    1,475.50
     XLON
    18-Sep-2025
    08:04:08
    0XL0617000000000ARCM30
    3
    1,475.50
     XLON
    18-Sep-2025
    08:04:08
    0XL0640000000000ARCLQC
    2
    1,475.50
     XLON
    18-Sep-2025
    08:04:08
    0XL0610000000000ARCLM1
    3
    1,475.50
     XLON
    18-Sep-2025
    08:04:08
    0XL0614000000000ARCLU5
    2
    1,475.50
     XLON
    18-Sep-2025
    08:04:08
    0XL0614000000000ARCLU6
    3
    1,475.50
     XLON
    18-Sep-2025
    08:04:08
    0XL06D0000000000ARCM2B
    12
    1,475.00
     XLON
    18-Sep-2025
    08:04:14
    0XL06A0000000000ARCM1S
    177
    1,475.00
     XLON
    18-Sep-2025
    08:04:14
    0XL0617000000000ARCM3H
    2
    1,474.00
     XLON
    18-Sep-2025
    08:06:26
    0XL0614000000000ARCM24
    3
    1,474.00
     XLON
    18-Sep-2025
    08:06:26
    0XL06A0000000000ARCM7P
    318
    1,474.00
     XLON
    18-Sep-2025
    08:06:26
    0XL0617000000000ARCM8E
    3
    1,474.00
     XLON
    18-Sep-2025
    08:06:26
    0XL0640000000000ARCLUE
    34
    1,473.50
     XLON
    18-Sep-2025
    08:06:35
    0XL0640000000000ARCLUK
    2
    1,473.50
     XLON
    18-Sep-2025
    08:06:35
    0XL0640000000000ARCLUL
    339
    1,473.00
     XLON
    18-Sep-2025
    08:06:37
    0XL0617000000000ARCM8T
    2
    1,474.50
     XLON
    18-Sep-2025
    08:07:17
    0XL06D0000000000ARCMB2
    163
    1,474.50
     XLON
    18-Sep-2025
    08:07:17
    0XL0617000000000ARCMA4
    2
    1,474.50
     XLON
    18-Sep-2025
    08:07:17
    0XL0614000000000ARCM3O
    3
    1,474.00
     XLON
    18-Sep-2025
    08:07:42
    0XL0640000000000ARCLVT
    2
    1,473.50
     XLON
    18-Sep-2025
    08:07:42
    0XL06D0000000000ARCMBF
    3
    1,474.00
     XLON
    18-Sep-2025
    08:09:15
    0XL06D0000000000ARCMGB
    2
    1,473.50
     XLON
    18-Sep-2025
    08:09:16
    0XL0614000000000ARCM7P
    3
    1,473.00
     XLON
    18-Sep-2025
    08:09:25
    0XL0611000000000ARCMAB
    64
    1,473.00
     XLON
    18-Sep-2025
    08:09:25
    0XL0617000000000ARCMG7
    2
    1,474.50
     XLON
    18-Sep-2025
    08:16:25
    0XL06D0000000000ARCN1R
    2
    1,474.50
     XLON
    18-Sep-2025
    08:16:25
    0XL0617000000000ARCMUG
    3
    1,474.50
     XLON
    18-Sep-2025
    08:16:25
    0XL06A0000000000ARCN17
    3
    1,474.50
     XLON
    18-Sep-2025
    08:16:25
    0XL06D0000000000ARCN1Q
    3
    1,474.00
     XLON
    18-Sep-2025
    08:16:48
    0XL06D0000000000ARCN2R
    3
    1,474.00
     XLON
    18-Sep-2025
    08:16:48
    0XL06A0000000000ARCN25
    2
    1,474.00
     XLON
    18-Sep-2025
    08:16:48
    0XL0617000000000ARCMVM
    2
    1,474.00
     XLON
    18-Sep-2025
    08:16:48
    0XL0640000000000ARCMFS
    3
    1,474.00
     XLON
    18-Sep-2025
    08:16:48
    0XL06D0000000000ARCN2Q
    214
    1,473.50
     XLON
    18-Sep-2025
    08:17:44
    0XL0617000000000ARCN14
    3
    1,473.50
     XLON
    18-Sep-2025
    08:17:44
    0XL0640000000000ARCMH9
    3
    1,473.50
     XLON
    18-Sep-2025
    08:17:44
    0XL0611000000000ARCMQN
    3
    1,473.50
     XLON
    18-Sep-2025
    08:17:44
    0XL0614000000000ARCMO5
    705
    1,472.50
     XLON
    18-Sep-2025
    08:19:20
    0XL0617000000000ARCN63
    684
    1,473.00
     XLON
    18-Sep-2025
    08:19:20
    0XL0617000000000ARCN62
    3
    1,473.00
     XLON
    18-Sep-2025
    08:19:20
    0XL06A0000000000ARCN7R
    3
    1,473.00
     XLON
    18-Sep-2025
    08:19:20
    0XL0610000000000ARCMMJ
    2
    1,473.00
     XLON
    18-Sep-2025
    08:19:20
    0XL0614000000000ARCMRN
    3
    1,473.00
     XLON
    18-Sep-2025
    08:19:20
    0XL0614000000000ARCMRM
    3
    1,473.00
     XLON
    18-Sep-2025
    08:19:20
    0XL0640000000000ARCMKK
    2
    1,471.50
     XLON
    18-Sep-2025
    08:20:35
    0XL0611000000000ARCN1E
    242
    1,471.50
     XLON
    18-Sep-2025
    08:20:35
    0XL0617000000000ARCN8E
    157
    1,471.00
     XLON
    18-Sep-2025
    08:21:42
    0XL0617000000000ARCNAQ
    2
    1,471.50
     XLON
    18-Sep-2025
    08:24:51
    0XL06A0000000000ARCNJ3
    3
    1,471.50
     XLON
    18-Sep-2025
    08:24:51
    0XL0640000000000ARCMRU
    3
    1,471.50
     XLON
    18-Sep-2025
    08:24:51
    0XL0617000000000ARCNEC
    178
    1,474.00
     XLON
    18-Sep-2025
    08:32:08
    0XL0617000000000ARCNT8
    3
    1,474.00
     XLON
    18-Sep-2025
    08:32:08
    0XL06D0000000000ARCO57
    4
    1,474.00
     XLON
    18-Sep-2025
    08:32:08
    0XL0614000000000ARCNK8
    2
    1,474.00
     XLON
    18-Sep-2025
    08:32:08
    0XL06D0000000000ARCO56
    3
    1,474.00
     XLON
    18-Sep-2025
    08:32:08
    0XL06A0000000000ARCO3Q
    3
    1,474.00
     XLON
    18-Sep-2025
    08:32:08
    0XL06D0000000000ARCO55
    2
    1,478.00
     XLON
    18-Sep-2025
    08:56:26
    0XL06D0000000000ARCPJA
    54
    1,478.00
     XLON
    18-Sep-2025
    08:56:26
    0XL0617000000000ARCPGN
    2
    1,478.00
     XLON
    18-Sep-2025
    08:56:26
    0XL06A0000000000ARCQ1P
    3
    1,478.00
     XLON
    18-Sep-2025
    08:57:28
    0XL0614000000000ARCP4N
    179
    1,478.00
     XLON
    18-Sep-2025
    08:57:28
    0XL0617000000000ARCPI7
    2
    1,478.00
     XLON
    18-Sep-2025
    08:57:28
    0XL0640000000000ARCOJD
    2
    1,478.00
     XLON
    18-Sep-2025
    09:00:29
    0XL0617000000000ARCPNO
    2
    1,478.00
     XLON
    18-Sep-2025
    09:00:29
    0XL0640000000000ARCOQ9
    4
    1,477.50
     XLON
    18-Sep-2025
    09:01:12
    0XL0610000000000ARCP5I
    4
    1,477.50
     XLON
    18-Sep-2025
    09:01:12
    0XL0614000000000ARCPCU
    1,036
    1,477.50
     XLON
    18-Sep-2025
    09:01:12
    0XL0617000000000ARCPOS
    4
    1,477.50
     XLON
    18-Sep-2025
    09:01:12
    0XL0617000000000ARCPOT
    3
    1,477.50
     XLON
    18-Sep-2025
    09:01:12
    0XL06A0000000000ARCQC5
    3
    1,477.50
     XLON
    18-Sep-2025
    09:01:12
    0XL0611000000000ARCPF2
    3
    1,477.50
     XLON
    18-Sep-2025
    09:01:12
    0XL06A0000000000ARCQC4
    3
    1,477.50
     XLON
    18-Sep-2025
    09:01:12
    0XL06D0000000000ARCPTB
    2
    1,477.50
     XLON
    18-Sep-2025
    09:01:12
    0XL06D0000000000ARCPTA
    2
    1,477.00
     XLON
    18-Sep-2025
    09:01:58
    0XL06D0000000000ARCPV2
    273
    1,477.00
     XLON
    18-Sep-2025
    09:01:58
    0XL0617000000000ARCPQD
    4
    1,477.00
     XLON
    18-Sep-2025
    09:01:58
    0XL0640000000000ARCOTN
    702
    1,477.00
     XLON
    18-Sep-2025
    09:01:58
    0XL0617000000000ARCPQE
    2
    1,477.00
     XLON
    18-Sep-2025
    09:01:58
    0XL0611000000000ARCPH1
    3
    1,476.50
     XLON
    18-Sep-2025
    09:04:54
    0XL06A0000000000ARCQL2
    3
    1,476.50
     XLON
    18-Sep-2025
    09:04:54
    0XL0640000000000ARCP45
    3
    1,476.50
     XLON
    18-Sep-2025
    09:04:54
    0XL0614000000000ARCPMJ
    3
    1,476.50
     XLON
    18-Sep-2025
    09:04:54
    0XL0614000000000ARCPMI
    3
    1,476.50
     XLON
    18-Sep-2025
    09:04:54
    0XL0640000000000ARCP44
    2
    1,476.50
     XLON
    18-Sep-2025
    09:04:54
    0XL0640000000000ARCP43
    384
    1,476.50
     XLON
    18-Sep-2025
    09:04:54
    0XL0617000000000ARCQ2M
    2
    1,476.50
     XLON
    18-Sep-2025
    09:04:54
    0XL0617000000000ARCQ2L
    2
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL0611000000000ARCPTI
    2
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL0614000000000ARCPPM
    217
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL0617000000000ARCQ6M
    2
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL0610000000000ARCPF7
    2
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL06A0000000000ARCQPB
    4
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL06D0000000000ARCQ9T
    613
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL0617000000000ARCQ6N
    2
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL06A0000000000ARCQPA
    2
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL0617000000000ARCQ6O
    3
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL06D0000000000ARCQ9S
    2
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL06D0000000000ARCQ9U
    2
    1,476.00
     XLON
    18-Sep-2025
    09:06:28
    0XL06D0000000000ARCQ9R
    3
    1,475.50
     XLON
    18-Sep-2025
    09:07:08
    0XL0614000000000ARCPQU
    2
    1,475.50
     XLON
    18-Sep-2025
    09:07:08
    0XL0611000000000ARCPV9
    3
    1,475.50
     XLON
    18-Sep-2025
    09:07:08
    0XL0640000000000ARCP7Q
    3
    1,475.50
     XLON
    18-Sep-2025
    09:07:08
    0XL0614000000000ARCPQV
    2
    1,475.50
     XLON
    18-Sep-2025
    09:07:08
    0XL0640000000000ARCP7P
    2
    1,475.00
     XLON
    18-Sep-2025
    09:08:10
    0XL06D0000000000ARCQDS
    3
    1,475.00
     XLON
    18-Sep-2025
    09:08:10
    0XL06D0000000000ARCQDR
    439
    1,475.00
     XLON
    18-Sep-2025
    09:08:10
    0XL0617000000000ARCQA4
    3
    1,475.00
     XLON
    18-Sep-2025
    09:08:10
    0XL06D0000000000ARCQDQ
    2
    1,475.00
     XLON
    18-Sep-2025
    09:08:10
    0XL06A0000000000ARCQU6
    3
    1,475.00
     XLON
    18-Sep-2025
    09:08:10
    0XL0617000000000ARCQA5
    2
    1,475.00
     XLON
    18-Sep-2025
    09:08:10
    0XL06A0000000000ARCQU7
    3
    1,475.00
     XLON
    18-Sep-2025
    09:08:10
    0XL0611000000000ARCQ25
    3
    1,475.00
     XLON
    18-Sep-2025
    09:08:10
    0XL0611000000000ARCQ24
    2
    1,476.00
     XLON
    18-Sep-2025
    09:19:54
    0XL0640000000000ARCPUS
    3
    1,476.00
     XLON
    18-Sep-2025
    09:19:54
    0XL0617000000000ARCR2U
    2
    1,476.00
     XLON
    18-Sep-2025
    09:19:54
    0XL06A0000000000ARCRNA
    3
    1,475.50
     XLON
    18-Sep-2025
    09:20:20
    0XL0640000000000ARCPVB
    2
    1,475.50
     XLON
    18-Sep-2025
    09:20:20
    0XL06A0000000000ARCROP
    2
    1,475.00
     XLON
    18-Sep-2025
    09:21:50
    0XL06A0000000000ARCRR3
    2
    1,475.00
     XLON
    18-Sep-2025
    09:21:50
    0XL06D0000000000ARCR9K
    2
    1,475.00
     XLON
    18-Sep-2025
    09:31:05
    0XL0640000000000ARCQFH
    2
    1,475.00
     XLON
    18-Sep-2025
    09:31:05
    0XL0610000000000ARCQTI
    2
    1,476.50
     XLON
    18-Sep-2025
    09:57:08
    0XL0610000000000ARCSDJ
    1,846
    1,477.50
     XLON
    18-Sep-2025
    10:07:24
    0XL0617000000000ARCTJN
    4
    1,478.00
     XLON
    18-Sep-2025
    10:23:37
    0XL0614000000000ARCU1I
    2
    1,477.50
     XLON
    18-Sep-2025
    10:24:17
    0XL0640000000000ARCT6S
    598
    1,477.00
     XLON
    18-Sep-2025
    10:25:01
    0XL0617000000000ARCUNS
    2
    1,477.00
     XLON
    18-Sep-2025
    10:25:01
    0XL0640000000000ARCT7T
    201
    1,477.00
     XLON
    18-Sep-2025
    10:25:01
    0XL0617000000000ARCUNR
    4
    1,477.00
     XLON
    18-Sep-2025
    10:25:01
    0XL0614000000000ARCU2P
    2
    1,476.50
     XLON
    18-Sep-2025
    10:25:43
    0XL0614000000000ARCU4D
    2
    1,476.50
     XLON
    18-Sep-2025
    10:25:43
    0XL0617000000000ARCUPL
    3
    1,476.50
     XLON
    18-Sep-2025
    10:25:43
    0XL06D0000000000ARCV4C
    3
    1,476.50
     XLON
    18-Sep-2025
    10:25:43
    0XL0614000000000ARCU4C
    2
    1,476.50
     XLON
    18-Sep-2025
    10:25:43
    0XL06D0000000000ARCV4D
    2
    1,476.50
     XLON
    18-Sep-2025
    10:25:43
    0XL0611000000000ARCUD4
    1,132
    1,476.50
     XLON
    18-Sep-2025
    10:25:43
    0XL0617000000000ARCUPM
    1
    1,476.50
     XLON
    18-Sep-2025
    10:25:43
    0XL0617000000000ARCUPN
    2
    1,476.50
     XLON
    18-Sep-2025
    10:25:43
    0XL06A0000000000ARCVMU
     
     
    GSK enquiries
     
     
     
    Media:
    Simon Steel
    +44 (0) 20 8047 5502
    (London)
     
    Kathleen Quinn
    +1 202 603 5003
    (Washington DC)
     
     
     
     
    Investor Relations:
    Constantin Fest
    +44 (0) 7831 826525
    (London)
     
    James Dodwell
    +44 (0) 20 8047 2406
    (London)
     
    Mick Readey
    +44 (0) 7990 339653
    (London)
     
    Steph Mountifield
    +44 (0) 7796 707505
    (London)
     
    Jeff McLaughlin
    +1 215 751 7002
    (Philadelphia)
     
    Frannie DeFranco
    +1 215 751 3126
    (Philadelphia)
     
    Cautionary statement regarding forward-looking statements
    GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2024, and GSK's Q2 Results for 2025.
     
    Registered in England & Wales:
    No. 3888792
     
    Registered Office:
    79 New Oxford Street
    London
    WC1A 1DG
     
     
     
    SIGNATURES
     
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
     
    GSK plc
     
    (Registrant)
     
     
    Date: September 19, 2025
     
     
     
     
    By:/s/ VICTORIA WHYTE
    --------------------------
     
     
     
    Victoria Whyte
     
    Authorised Signatory for and on
     
    behalf of GSK plc
    Get the next $GSK alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GSK

    DatePrice TargetRatingAnalyst
    6/3/2025Buy → Hold
    Berenberg
    4/15/2025$35.25Neutral
    Exane BNP Paribas
    2/12/2025Equal-Weight
    Morgan Stanley
    11/15/2024Buy → Hold
    Deutsche Bank
    11/12/2024$53.00 → $39.50Buy → Hold
    Jefferies
    10/31/2024Buy → Neutral
    Guggenheim
    7/8/2024Buy → Neutral
    UBS
    5/30/2024$47.00Neutral
    Goldman
    More analyst ratings

    $GSK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level

    New analysis of metro-area data reveals wide variation in adult vaccination trends across the US and points to opportunities for local action Originally launched in 2022, Vaccine Track remains the only publicly accessible source for month-by-month immunization trends across a variety of adult vaccines, enabling analyses that could uncover possible drivers Vaccine Track can help public health organizations and providers identify gaps and better target their efforts GSK plc (LSE/NYSE:GSK) today announced a major update to Vaccine Track, a first-of-its-kind, interactive public data tool for tracking adult immunization activity in the US. Users can now explore vaccination trends acros

    10/1/25 10:00:00 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Multiple Myeloma Research Foundation Unites Patients and Advocates to Hike New Hampshire's White Mountains to Accelerate a Cure for Multiple Myeloma

    NORWALK, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Multiple Myeloma Research Foundation® (MMRF®) today announced that a team of hikers, including multiple myeloma patients and advocates, will take on the rugged trails of New Hampshire's White Mountains as part of the Moving Mountains for Multiple Myeloma® (MM4MM) program. Sponsored by GSK plc (LSE/NYSE:GSK), the trek aims to raise awareness of multiple myeloma and generate critical funds to accelerate a cure for multiple myeloma. The hike will take place October 5 – 9, 2025. "Now in its ninth year, MM4MM has made tremendous progress and united hundreds of patients, caregivers, and supporters to raise funds that go directly to advancing

    10/1/25 7:00:00 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

    Includes license for potential best-in-class PDE3/4 inhibitor (HRS-9821) in clinical development for treatment of COPDAdditional 11 programmes to be developed by Hengrui Pharma and optioned by GSK following phase I completionJIANGSU, China, July 27, 2025 /PRNewswire/ -- Hengrui Pharma (600276.SH; 01276.HK) today announced it has entered into agreements with GSK plc (LSE/NYSE:GSK) to develop up to 12 innovative medicines, adding significant value to the globalization strategy of Hengrui and significant new growth opportunities to GSK beyond 2031. The programmes were selected to complement GSK's extensive Respiratory, Immunology & Inflammation (RI&I) and Oncology pipeline, and assessed for the

    7/27/25 9:53:00 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GSK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GlaxoSmithKline downgraded by Berenberg

    Berenberg downgraded GlaxoSmithKline from Buy to Hold

    6/3/25 7:26:51 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Exane BNP Paribas initiated coverage on GlaxoSmithKline with a new price target

    Exane BNP Paribas initiated coverage of GlaxoSmithKline with a rating of Neutral and set a new price target of $35.25

    4/15/25 12:40:46 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Morgan Stanley initiated coverage on GlaxoSmithKline

    Morgan Stanley initiated coverage of GlaxoSmithKline with a rating of Equal-Weight

    2/12/25 7:05:11 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GSK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: GLAXOSMITHKLINE PLC converted options into 700,772 units of Common Stock and bought $4,950,000 worth of Common Stock (275,000 units at $18.00)

    4 - GLAXOSMITHKLINE PLC (0001131399) (Reporting)

    7/6/21 4:38:14 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by GLAXOSMITHKLINE PLC

    3 - GLAXOSMITHKLINE PLC (0001131399) (Reporting)

    7/6/21 4:22:59 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4: GLAXOSMITHKLINE PLC converted options into 30,253,189 units of Common Stock

    4 - GLAXOSMITHKLINE PLC (0001131399) (Reporting)

    6/23/21 6:14:59 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GSK
    SEC Filings

    View All

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    10/3/25 6:13:50 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    10/2/25 6:51:18 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    10/1/25 10:10:01 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GSK
    Financials

    Live finance-specific insights

    View All

    Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

    Highlights Second quarter revenue grew 15% year-over-year to $212 million, driven by Prenatal (25%), Pharmacogenomics (22%), and Hereditary Cancer (19%).Second quarter GAAP earnings per share improved to $(0.41) from $(1.42) in the second quarter of 2023; adjusted earnings per share improved to $0.05 from $(0.08) in the second quarter of 2023.Increasing 2024 financial guidance with full year revenue moving to a range of $835 - $845 million, or an annual growth rate of between 11% and 12%, and increasing adjusted earnings per share (EPS) to a range of $0.08 - $0.12.1 _________________________1 The company does not forecast GAAP EPS because it cannot predict certain elements that are include

    8/6/24 4:05:00 PM ET
    $GSK
    $MYGN
    $PSNL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Medical Specialities

    GSK and CureVac to Restructure Collaboration into New Licensing Agreement

    GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinationsCureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replacedLONDON, UK, TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / July 3, 2024 / GSK plc (NYSE:GSK) and CureVac N.V. (NASDAQ:CVAC) today announced they have restructured their existing collaboration into a new licensing agreement, allowing each company to prioritize investment and focus their respective mRNA

    7/3/24 2:40:00 AM ET
    $CVAC
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    23andMe Reports Third Quarter Fiscal 2024 Financial Results

    SOUTH SAN FRANCISCO, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME), a leading human genetics and biopharmaceutical company, reported its financial results for the third quarter of fiscal year 2024 (FY24), which ended December 31, 2023. Key Results Reported total revenue of $44.7 million in the third quarter of fiscal 2024, compared to $66.9 million in the third quarter of fiscal 2023, a decrease of approximately 33% due to lower research revenue after the conclusion of the GSK collaboration exclusivity term in July 2023 and lower PGS kit volumes.Announced a non-exclusive data license with GSK plc (NYSE:GSK) for novel drug target discovery and other research. U

    2/7/24 4:01:00 PM ET
    $GSK
    $ME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GSK
    Leadership Updates

    Live Leadership Updates

    View All

    GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis

    Pretty Hurts, a new Lifetime Original Movie brought to you by GSK, informs Lifetime's mom audience about meningococcal disease, known as meningitis Partnership is part of GSK's Ask2BSure campaign, which encourages parents of teens and young adults ages 16-23 to start a conversation with their teen's doctor about meningitis and vaccination Hollywood moms of teens, Alyson Hannigan and Sarah Michelle Gellar, team up with GSK and Ask2BSure to help raise awareness GSK plc (LSE/NYSE:GSK) today announced its sponsorship of Pretty Hurts, a gripping new Lifetime Original Movie and the latest extension of GSK's Ask2BSure public health campaign. Premiering on June 28, 2025, at 8 p.m. ET/7 p.m.

    5/9/25 9:00:00 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GeminiBio Appoints Mike Stella to Board

    Strengthening Board with Industry Veterans Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based healthcare private equity firm, announced today the appointment of Michael Stella to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218608576/en/Mike Stella, CEO of Ascend Advanced Therapies, joins the Board at GeminiBio to provide strategic leadership in the fields of cell and gene therapy contract development and manufacturing. (Photo: Business Wire) GeminiBio prov

    2/18/25 9:00:00 AM ET
    $AMGN
    $GSK
    $JNJ
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

    TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd (NASDAQ:MDCX, TSXV:MDCX) (the "Company") is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical Officer. "We are thrilled to welcome Dr. Mehmud to our leadership team," stated Dr. Raza Bokhari, Exec. Chairman & CEO. "Faisal has a proven track record in integrating cutting-edge science with practical, evidence-based medical strategies to develop partnerships and launch high impact therapies. We aim to capitalize on his experience and expertise to expand our drug development pipeline and foster collaboration with strategic partners to bring to market our novel non-invasive patented dissolvab

    11/18/24 7:30:00 AM ET
    $GSK
    $MDCX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GSK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GSK plc

    SC 13G/A - GSK plc (0001131399) (Subject)

    11/12/24 4:32:59 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by GSK plc (Amendment)

    SC 13G/A - GSK plc (0001131399) (Subject)

    2/13/24 1:37:25 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by GSK plc (Amendment)

    SC 13G/A - GSK PLC (0001131399) (Subject)

    2/14/23 1:54:01 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care